AV 5124
Alternative Names: AV-5124Latest Information Update: 08 Jan 2024
At a glance
- Originator Viriom
- Class Antivirals
- Mechanism of Action Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Influenza virus infections
Most Recent Events
- 20 Nov 2023 Phase-I clinical trials in Influenza virus infections (PO) before November 2023
- 20 Nov 2023 Efficacy and adverse events data from a phase I trial in Influenza virus infections released by Viriom
- 20 Nov 2023 Pharmacodynamics data from a preclinical trial in Influenza virus infections released by Viriom